|
NOC3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.442700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.689800E-02 |
| Normal-vs-Stage2 |
4.081600E-01 |
| Normal-vs-Stage3 |
1.256590E-01 |
| Normal-vs-Stage4 |
4.847900E-02 |
| Stage1-vs-Stage2 |
8.943400E-01 |
| Stage1-vs-Stage3 |
4.996800E-01 |
| Stage1-vs-Stage4 |
1.474220E-01 |
| Stage2-vs-Stage3 |
5.967000E-01 |
| Stage2-vs-Stage4 |
2.084800E-01 |
| Stage3-vs-Stage4 |
4.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.063950E-02 |
| Normal-vs-AfricanAmerican |
4.979700E-02 |
| Normal-vs-Asian |
3.123800E-01 |
| Caucasian-vs-AfricanAmerican |
6.645200E-01 |
| Caucasian-vs-Asian |
4.783000E-01 |
| AfricanAmerican-vs-Asian |
6.328200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.970100E-02 |
| Normal-vs-Female |
1.581090E-04 |
| Male-vs-Female |
4.323300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.477400E-01 |
| Normal-vs-Extreme_Weight |
4.350800E-01 |
| Normal-vs-Obese |
1.255970E-03 |
| Normal-vs-Extreme_Obese |
8.571600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.518600E-01 |
| Normal_Weight-vs-Obese |
8.315700E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.994600E-01 |
| Extreme_Weight-vs-Obese |
1.867610E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.215200E-01 |
| Obese-vs-Extreme_Obese |
1.072750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.043920E-02 |
| Normal-vs-Age(41-60Yrs) |
3.957000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.571250E-01 |
| Normal-vs-Age(81-100Yrs) |
3.964100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.909500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.646100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.277700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.860500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.426700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.638190E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.400090E-02 |
| Normal-VS-Type2 PRCC |
7.006600E-01 |
| Normal-VS-KIRP CIMP |
1.426100E-02 |
| Normal-VS-Unclassified PRCC |
1.778150E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.345200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.276300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.525560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.799680E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.652000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.170100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.621400E-01 |
| Normal-vs-N1 |
5.179500E-03 |
| Normal-vs-N2 |
6.870400E-01 |
| N0-vs-N1 |
4.838600E-03 |
| N0-vs-N2 |
5.426400E-01 |
| N1-vs-N2 |
5.161800E-01 |
|
|
